BIOREGENX INC. (BRGX) Annual Balance Sheets

Annual · GAAP · USD millions
Access BRGX quarterly Balance Sheets →
The table below presents a historical view of BIOREGENX INC.'s balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2021)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Accounts receivable0.04
Other Receivables0.00
Inventories0.11
Total loans net0.01
Total Current Assets0.25
Equipment/Property/Plant Net0.16
Intangible Assets0.00
Long-term investments0.00
Accounts Receivable, Net, Noncurrent0.00
Total Assets0.41
Liabilities
Accounts Payable0.62
Accrued Liabilities, Current0.43
Short-term Debt1.00
Deferred Liability and Revenue0.06
Total Current Liabilities4.07
Long-term debt0.18
Capital Lease and Other0.00
Long-term Debt Convertible0.00
Total Long-term Debt0.18
Total Liabilities4.95
Stockholders' Equity
Common Stock Value0.97
Additional Paid In Capital Common Stock31.61
Retained Earnings / Accumulated Deficit-37.12
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-4.54
Total Stockholder's Equity-4.54
Liabilities & Stockholder's Equity0.41
4 historic quarters locked

Sign in to unlock the full BIOREGENX INC. balance sheet history.

About Bioregenx Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-002975

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License